Beta Bionics, Inc. Common Stock (BBNX) financials · rev $100.3M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Beta Bionics, Inc. Common Stock (BBNX) rev $100.3M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $100.3M | $65.1M |
| Cost of Revenue | $44.7M | $29.2M |
| Gross Profit | $55.5M | $35.9M |
| Operating Income | -$71.7M | -$45.3M |
| Net Income | -$73.2M | -$54.8M |
| EPS (Diluted) | -$1.81 | -$8.60 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $328.7M | $149.6M |
| Current Assets | $267.9M | $132.9M |
| Cash & Equivalents | $31.6M | $30.4M |
| Inventory | $21.7M | $13.3M |
| PP&E | $8.60M | $4.78M |
| Total Liabilities | $41.1M | $73.6M |
| Current Liabilities | $30.9M | $21.1M |
| Shareholders' Equity | $287.6M | -$245.4M |
| Retained Earnings | -$369.9M | -$296.7M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$50.9M | -$48.3M |
| CapEx | $5.30M | $3.40M |
| Investing Cash Flow | -$162.8M | -$3.48M |
| Financing Cash Flow | $214.9M | $55.6M |
| Net Change in Cash | $1.14M | $3.87M |
| Free Cash Flow | -$56.2M | -$51.7M |
FAQ
What is BBNX P/E and revenue?
Beta Bionics, Inc. Common Stock (BBNX) rev $100.3M.
What is BBNX revenue?
Beta Bionics, Inc. Common Stock last cached revenue is $100.3M (FY2025).
Is BBNX profitable?
Beta Bionics, Inc. Common Stock last cached net income is -$73.2M (FY2025).
What are BBNX total assets?
Beta Bionics, Inc. Common Stock last cached total assets are $328.7M (FY2025).
What is BBNX free cash flow?
Beta Bionics, Inc. Common Stock last cached free cash flow is -$56.2M (FY2025).
Not investment advice. Cached statements, not a live tape.